Irish medtech firm Neuromod Devices sets up US subsidiary

The company, which specialises in treatment of tinnitus, announces three US-based executive appointments as it seeks FDA approval for its product

26th August, 2021
Irish medtech firm Neuromod Devices sets up US subsidiary
Ross O’Neill, chief executive of Neuromod Devices, said the company aims to meet the needs of the estimated 50 million people in the US with tinnitus. Picture: Fergal Phillips

Neuromod Devices, the Irish medical device company specialising in the treatment of tinnitus, has announced the establishment of Neuromod USA Inc, a subsidiary headquartered in Oak Brook, Illinois.

The company also announced the appointment of three executives to Neuromod USA’s leadership team as the newly formed business prepares to enter the US market with its medical device for tinnitus treatment, pending approval from the Food and Drug Administration.

Stephanie Glowacki has been appointed...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Related Stories

Core chief executive Alan Cox to step down after 15 years

Wazp invests €2m to open on-demand manufacturing centre

John Walsh: Breaking the corporate glass ceiling starts with dismantling the customs that frame it